603858.SH
步长制药
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 15.18
−2.19%Margins
Gross margin
63.3%
EBITDA margin
9.2%
EBIT margin
4.9%
Net margin
3.2%
FCF margin
2.9%
3.7%
Return on equity
1.9%
Return on assets
4.3%
Return on invested capital
0.60x
Asset turnover
CNY 444.3M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026